Follow the 알테오젠 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 알테오젠 has logged 30 reports. The latest transaction was disclosed on 11 December 2024 (Other). Among the most active insiders: 전태연. All data is openly available.
30
Insider Decl.
n/a
Thresholds
n/a
21 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Alteogen is a biopharmaceutical company focused on developing innovative drugs for the treatment of cancer and other diseases. It is listed on the XKRX market.
